Like TGaS Advisors, LLC

closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/25/2020 via BusinessWire

W2O Group, acquired Elysia Group

synopsis: W2O, the leading independent provider of analytics-driven, technology-enabled marketing and communications solutions to the healthcare sector, announced it has acquired Elysia Group, a health economic and outcomes research (HEOR) consulting firm operating in the United States and Asia Pacific.
buyer parent: New Mountain Capital, LLC
buyer: W2O Group
W2O is an independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. "
target: Elysia Group
Elysia Group is a health economic and outcomes research consulting firm. Elysia provides pharmaceutical and medical device clients with innovative modeling approaches to health economic strategy and evidence development using data and analytics and real-world evidence.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/7/2020 via BNC Analysis

Integrated Medhealth Communication, acquired Porterhouse Medical Group

synopsis: Porterhouse Medical Group is joining imc group with the support of Waterland Private Equity. Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry.
buyer parent: Waterland Private Equity Investments
buyer: Integrated Medhealth Communication
Founded in 2006, Integrated Medhealth Communication (IMC) provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including eight of the 20 largest drug companies in the world. "
target: Porterhouse Medical Group
Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry, with a focus on activities that have a beneficial and measurable impact on healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/4/2019 via BusinessWire

Pharmerit International merged with Open Health,

synopsis: OPEN Health, a leading multi-disciplinary health communications and market access group, has merged with Pharmerit International, LP, the largest independent global provider of health economics and outcomes research and strategic market access services to the pharmaceutical industry.
buyer parent: Amulet Capital Partners LP
buyer: Open Health
OPEN Health is a multi-disciplinary health communications and market access group, operating across three core business areas: Medical Communications; Patient and Brand Communications; and Value, Informatics and Evidence. "
target: Pharmerit International
Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in HEOR and market access worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2018 via Company Press Release

The WIRB-Copernicus Group, acquired KMR Group

synopsis: WIRB-Copernicus Group (WCG), the leading provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired KMR Group, a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: KMR Group
KMR Group is a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry. KMR offers leading-edge data, products, and services in the form of reports and on-line tools that inform client strategy and productivity as well as day-to-day operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/2/2018 via PR Newswire

ZS Associates, purchased BASES Pharmaceutical Forecasting from The Nielsen Company, Inc.

synopsis: ZS announced it has acquired the assets of BASES Pharmaceutical Forecasting from Nielsen. The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
buyer: ZS Associates
ZS Associates is a global management consulting firm specializing in sales and marketing strategy, operations and execution. Founded in 1983, ZS has grown into a firm of 500 professionals delivering expertise across much of the sales and marketing spectrum. "
seller: The Nielsen Company, Inc. (NLSN:$6,465.00)
The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/10/2014 via Company Press Release

Cello Group, acquired Promedica, Inc

synopsis: Cello Group plc, the healthcare and consumer strategic marketing group, is pleased to announce the acquisition of Worldwide Promedica Inc. Promedica is a San Francisco based market research firm serving pharmaceutical and biotechnology companies.
buyer: Cello Group (CLLL:$204.91)
Cello is a leading global insight and strategic marketing group with a primary focus on the pharmaceutical and health sectors in addition to deep expertise in a range of other high margin sectors. "
target: Promedica, Inc
Promedica’s mission is to provide primary marketing research in the area of new product planning with an exclusive focus on healthcare, and a client-side perspective. Their ultimate goal is to optimize client's marketing research investment and contribute to company’s success.
price ($mm)
$0.70
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.3x
EV / EBITDA
closed 11/20/2014 via Company Press Release

TGaS Advisors, LLC, acquired TGaS Advisors, LLC

synopsis: TGaS® Advisors, the premier provider of benchmarking and advisory services to the commercial operations organizations of pharmaceutical and biotechnology companies, has been acquired by Trientis Vitae, a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. TGaS had been owned by ABRY Partners since 2010.
buyer parent: Geminin Investors, LLC
buyer: TGaS Advisors, LLC
Trientis Vitae is a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. The buyout was sponsored by Gemini Investors which led a consortium of investors including Triangle Capital Corporation, Tregaron Capital Company and Salem Investment Partners. "
target parent: ABRY Partners, LLC
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2013 via BusinessWire

Audax Group, acquired Chesapeake Research Review

synopsis: Audax Group announced it has completed the recapitalization of Chesapeake Research Review, Inc. Chesapeake is a leading provider of independent institutional review board (“IRB”) services to major pharmaceutical, biotech and medical device companies, universities, academic medical centers, and hospital systems.
buyer: Audax Group
Audax Group, founded in 1999, is a leading investor in lower-middle market companies. With offices in Boston and New York, Audax has over $5 billion in assets under management in its Private Equity, Mezzanine, and Senior Debt businesses. "
target: Chesapeake Research Review
Chesapeake Research Review, Inc. provides human research protections services. It offers institutional review board services & human research protections consultation, including strategic & operational, IRB consultation services; ethical, scientific & applied bioethics review, education & auditing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2012 via PR Newswire

McCann Health, acquired Double Helix

synopsis: McCann Health announced the acquisition of Double Helix. Double Helix is a leading, global provider of Market Research and Market Access services to the pharmaceutical and medical device industries. Dr. Wayne Phillips, who founded and runs Double Helix, will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
buyer parent: Interpublic Group of Companies, Inc.
buyer: McCann Health
Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. "
target: Double Helix
Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in 1995, they have been providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses.
price ($mm)
$55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2012 via Market Wire

ImpactRx, Inc., acquired Source Healthcare Analytics, LLC

synopsis: Symphony Technology Group announced that it has acquired Source Healthcare Analytics, LLC. STG will combine Source Healthcare Analytics with ImpactRx to form Symphony Health Solutions, which will be focused on delivering high-value data, analytics, and technology based solutions for clients across life science manufacturers, payers, and providers.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target parent: Wolters Kluwer NV
target: Source Healthcare Analytics, LLC
Source Healthcare Analytics is a leading provider of information and analytics to the pharmaceutical, biotech and financial industries. The company's brands include Source®, ProMetis™ and inThought™.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/17/2012 via PR Newswire

Campbell Alliance Group, Inc., will purchase Promotional and Medical Audit Businesses from SDI Health LLC

synopsis: inVentiv Health, Inc. has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Campbell Alliance Group, Inc.
Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. "
seller parent: TPG Capital
seller: SDI Health LLC
SDI Health is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/7/2011 via BNC Analysis

Market Probe, acquired Richard Day Research Inc.

synopsis: Market Probe has announced the acquisition of Richard Day Research Inc. (RDR), a specialist in financial services and pharmaceutical research based in Evanston, IL. RDR employs a range of methods from quantitative surveys of clients and prospects, to internal analyses of customer databases.
buyer: Market Probe
Market Probe is a global market research firm providing full-service strategic guidance and business solutions to major international companies. It specializes in customer satisfaction, employee and brand stakeholder marketing research, with in-house facilities for field services by Web and phone. "
target: Richard Day Research Inc.
Richard Day Research Inc. is a specialist in financial services and pharmaceutical research based in Evanston, IL. Its specialties include advanced analytics, brand support, data collection, general public surveys, marketing effectiveness & win/loss, qualitative research, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/4/2011 via BNC Analysis

LA-SER Alpha Group Sarl, will acquire Analytica International, Inc.

synopsis: Accentia Biopharmaceuticals, Inc. announced that it has entered into an agreement to sell the assets of its non-strategic business unit, Analytica International, Inc., a healthcare economics consulting firm to LA-SER, a London-based pharma research company.
buyer: LA-SER Alpha Group Sarl
LA-SER was founded in 2004, with a mission to bring cutting-edge scientific methodology to evaluate the real-world impact of medicines. Their goal is to find for whom and under which conditions of use the drugs will demonstrate best benefit to patients, with minimal harm. "
target parent: Accentia Biopharmaceuticals, Inc.
target: Analytica International, Inc.
Analytica Group, Inc., a healthcare consultancy firm, provides pharmaceutical research and analysis solutions.
price ($mm)
$4.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2011 via BNC Analysis

IMS Health Incorporated, acquired SDI Health LLC

synopsis: IMS Health has completed its acquisition of SDI, a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations. "
target parent: LLR Partners
target: SDI Health LLC
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
$340
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/6/2010 via Company Press Release

KnowledgePoint360 Group, LLC, acquired TGaS Advisors, LLC

synopsis: KnowledgePoint360 Group, a global leader in communications and information services for healthcare professionals, has acquired TGaS Advisors, LLC, the premier provider of benchmark-based advisory services to the pharma and biotech industry.
buyer parent: ABRY Partners
buyer: KnowledgePoint360 Group, LLC
KnowledgPoint360 provides a broad range of medical communications services, including medical education, publication support, live educational meetings, scientific content development, exhibit design, digital solutions, training, workflow and compliance solutions. "
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 1/19/2010 via PR Newswire

Decision Resources, Inc., acquired BioTrends Research Group, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2014 via Company Press Release

TGaS Advisors, LLC, acquired TGaS Advisors, LLC

synopsis: TGaS® Advisors, the premier provider of benchmarking and advisory services to the commercial operations organizations of pharmaceutical and biotechnology companies, has been acquired by Trientis Vitae, a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. TGaS had been owned by ABRY Partners since 2010.
buyer parent: Geminin Investors, LLC
buyer: TGaS Advisors, LLC
Trientis Vitae is a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. The buyout was sponsored by Gemini Investors which led a consortium of investors including Triangle Capital Corporation, Tregaron Capital Company and Salem Investment Partners. "
target parent: ABRY Partners, LLC
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/6/2010 via Company Press Release

KnowledgePoint360 Group, LLC, acquired TGaS Advisors, LLC

synopsis: KnowledgePoint360 Group, a global leader in communications and information services for healthcare professionals, has acquired TGaS Advisors, LLC, the premier provider of benchmark-based advisory services to the pharma and biotech industry.
buyer parent: ABRY Partners
buyer: KnowledgePoint360 Group, LLC
KnowledgPoint360 provides a broad range of medical communications services, including medical education, publication support, live educational meetings, scientific content development, exhibit design, digital solutions, training, workflow and compliance solutions. "
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/1/2019 via BusinessWire

Trinity, acquired Bell Canyon Consulting

synopsis: TRINITY, the global life sciences commercialization solutions provider, has acquired Bell Canyon Consulting, a data management consulting company with core expertise in master data management, data warehousing, business intelligence, and other information technology services.
buyer parent: Parthenon Capital Partners
buyer: Trinity
TRINITY is a global commercialization partner to the life sciences industry, providing evidence-based solutions throughout the product lifecycle. TRINITY is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. "
target: Bell Canyon Consulting
Bell Canyon Consulting is a data management consulting company with core expertise in master data management, data warehousing, business intelligence, and other information technology services. Bell Canyon’s mission is to enable life sciences clients to drive revenue.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/19/2013 via BusinessWire

Huron Consulting Group Inc., will acquire The Frankel Group Associates LLC

synopsis: Huron Consulting Group, a leading provider of business consulting services, announced that it has entered into an agreement to acquire the assets of The Frankel Group Associates LLC, a life sciences consulting firm. The acquisition will expand Huron’s strategy, advanced analytics, and regulatory compliance offerings to life sciences clients.
buyer: Huron Consulting Group Inc. (HURN:$892.03)
Huron Consulting Group helps clients in diverse industries improve performance, comply with complex regulations, reduce costs, recover from distress, leverage technology, and stimulate growth. The Company teams with its clients to deliver sustainable and measurable results. "
target: The Frankel Group Associates LLC
Frankel Group is a leading strategy consulting firm with offices in New York City, Cambridge, Massachusetts, and Tel Aviv, Israel that has served the life science industry and related segments since 1993.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2013 via BNC Analysis

DrugDev, acquired CFS Clinical

synopsis: DrugDev, an interactive network and data sharing platform for over 80,000 clinical trial doctors in 93 countries, announced its acquisition of CFS Clinical (CFS), the leading specialty provider focused on the business and financial management activities for clinical trials.
buyer: DrugDev
DrugDev helps the clinical trials industry run faster, cheaper and smarter trials. Experienced Investigators choose to be part of the free network to access new clinical trial opportunities they would not otherwise have learnt about. "
target: CFS Clinical
CFS Clinical (CFS) is a technology-enabled service provider focused on the business and financial management activities for clinical trials.CFS’ experts deliver best-in-class Investigator site payment and study startup solutions around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2019 via BusinessWire

Validant, acquired DataRevive LLC

synopsis: Validant, a leading transatlantic quality, compliance and regulatory consulting group, has acquired DataRevive, a regulatory strategy and consultancy firm that focuses on supporting pharma and biotech to navigate the regulatory approval pathway for global clients in the US market.
buyer parent: GHO Capital
buyer: Validant
Validant is a leading international Quality, Compliance, and Regulatory consulting firm, blending industry expertise with innovation to create custom solutions for companies on the frontier of health. "
target: DataRevive LLC
DataRevive is a leading Regulatory Affairs consulting firm, providing high quality advice and expertise from the perspective of industry and regulators to support customers from across pharma and biotech as they seek to navigate the regulatory approval process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/3/2015 via PR Newswire

Publicis Touchpoint Solutions, Inc., acquired Tardis Medical Consultancy

synopsis: Publicis Healthcare (PHCG) announced that it has acquired Tardis Medical, a highly respected clinical and medical affairs outsourcing organization and consultancy business. The agency will be aligned with Publicis Touchpoint Solutions, part of PHCG, Inc—a leading provider of customized, omnichannel healthcare sales, service, and clinical teams.
buyer parent: Publicis Groupe SA
buyer: Publicis Touchpoint Solutions, Inc.
Publicis Touchpoint Solutions designs and implements customized healthcare sales, service, and communications teams. They provide field sales and service, live video detailing, inside credentialed sales specialists, inside sales and service, clinical health educators, and medical science liaisons. "
target: Tardis Medical Consultancy
Tardis Medical is a Clinical and Medical Affairs consultancy, enabling pharmaceutical and life sciences companies to work as effectively as possible through: consultancy on strategic issues and operational matters, capabilities development, and resource augmentation of field based consultants.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/18/2012 via BusinessWire

Adjility Health will be merged with Alliance Life Sciences Consulting Group, Inc,

synopsis: Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, and Adjility Consulting, a consulting firm specializing in management consulting and analytic solutions for clinical operations and the global market access, pricing and reimbursement space, announced that the two companies will merge.
buyer: Alliance Life Sciences Consulting Group, Inc
Alliance Life Sciences Consulting Group employs more than 175 professionals who collectively understand the business challenges of the Life Sciences industry and offer solutions for Sales & Marketing, Managed Care & Government Contracting, Commercial Operations, Information Management and Analytics."
target: Adjility Health
Adjility Health is dedicated to helping healthcare companies improve their operations through the use of strategic consulting services and very industry domain-specific analytic, forecasting, predictive trending and other data insight tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via Company Press Release

Advarra, acquired Kinetiq

synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent: Linden Capital Partners
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/21/2018 via BusinessWire

GHO Capital, acquired Validant

synopsis: GHO Capital, the European specialist investor in healthcare, has acquired a majority stake in Validant. Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
buyer: GHO Capital
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. They apply global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market leading businesses of strategic global value."
target: Validant
Operating globally with offices in Europe and North America, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2018 via PR Newswire

Premier Research Group, acquired Regulatory Professionals, Inc.

synopsis: Premier Research, a global provider of clinical development services to biopharmaceutical product innovators, has acquired Regulatory Professionals, Inc. (RPI), a California-based company that provides regulatory expertise and solutions to biotechnology, pharmaceutical, and medical device companies.
buyer parent: ECI Partners
buyer: Premier Research Group
Premier Research is a leading clinical development service provider that helps biotech and specialty pharma innovators — small companies with big ambitions — transform life-changing ideas into new medicines. "
target: Regulatory Professionals, Inc.
Regulatory Professionals, Inc. (RPI) provides strategic advice, regulatory planning, and a full range of submission services, helping its clients advance the development and registration of their products in worldwide markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2018 via Company Press Release

Bertram Capital Management LLC, acquired Registrar Corp

synopsis: Bertram Capital announced its investment in Registrar, LLC, a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
buyer: Bertram Capital Management LLC
Bertram Capital is a private equity firm targeting investments in lower middle market companies. By supplying flexible investment capital and committing a wealth of operational and strategic resources, they make their core objective to move companies toward unlocking their full potential. "
target: Registrar Corp
Registrar Corp is a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via Company Press Release

Linden Capital Partners, acquired ProPharma Group

synopsis: Linden Capital Partners, a Chicago-based healthcare private equity firm, announced that it has completed its acquisition of ProPharma Group. ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
buyer: Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. "
target: ProPharma Group
ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/27/2013 via Company Press Release

Cumberland, purchased Life Sciences Consulting Division from Mindlance

synopsis: Cumberland Consulting Group LLC, has purchased the Mindlance Life Sciences Consulting division of Mindlance Inc., a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
buyer parent: Tailwind Capital Partners
buyer: Cumberland
Cumberland Consulting provides healthcare IT consulting services, including, Planning & Assessment; Workflow Management; Vendor Selection; Software Implementation; and Project Management to healthcare organizations. "
seller: Mindlance
Mindlance Inc., is a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2012 via BusinessWire

Dohmen Company, acquired BioSoteria, Inc.

synopsis: The Dohmen Company has acquired BioSoteria, a leading provider of drug safety and risk management services to the biopharmaceutical industry. The BioSoteria management team has experience building drug safety departments from the ground up at start-up companies and expanding pharmacovigilance capabilities for larger companies.
buyer: Dohmen Company
Dohmen is a provider of outsourced business services. Dohmen’s portfolio of service offerings includes outsourced business services to life science manufacturers through DDN, and benefit management services to life science payers through RESTAT. "
target: BioSoteria, Inc.
BioSoteria provides a broad range of drug safety services to the biopharmaceutical industry. BioSoteria helps companies manage the safety of their products with a regulatory-compliant, best-practices approach. Being a trusted pharmacovigilance service provider begins with leadership.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/11/2019 via PR Newswire

Indegene Lifesystems Pvt Ltd., acquired DT Associates

synopsis: Indegene, a global next-generation solutions company in the Life Sciences industry, has acquired London-based DT Associates, a consulting company focused on helping pharmaceutical companies achieve excellence in Customer Experience and Digital Operations. DT Associates will operate as a separate entity in Indegene Private Ltd, as DT Consulting.
buyer: Indegene Lifesystems Pvt Ltd.
Indegene enables global health care companies to address complex challenges and drive better health and business outcomes by integrating analytics, technology, operations, and medical expertise. Indegene drives innovation by combining medical expertise with contemporary digital and AI technologies. "
target: DT Associates
London-based DT Associates helps pharmaceutical firms achieve digital excellence to create successful customer experiences. DT uses fact-based insights from curated research, assessments, benchmarks, consulting projects, and more to address digital transformation in the pharmaceutical industry.
price ($mm)
$12
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via Company Press Release

UDG Healthcare plc, acquired Putnam Associates

synopsis: UDG Healthcare plc, a leading international healthcare services provider, announces the acquisition of Putnam Associates, a company that provides strategic advice based on sophisticated and robust analytics to biopharmaceutical, diagnostics, and medical device clients.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Putnam Associates
Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/7/2018 via BNC Analysis

Ancor Capital Partners, acquired STATinMed

synopsis: Ancor Capital Partners, a Dallas-based private equity firm, announces the acquisition of STATinMED Research, a leading medical technology company in the health economics and outcomes research industry. STATinMED provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies.
buyer: Ancor Capital Partners
Ancor Capital Partners is an operations-oriented private equity firm focused on lower middle-market companies with EBITDA of $5-$15 million. Extensive operational experience gives the Ancor team a unique understanding of the critical business issues faced by lower middle-market companies. "
target: STATinMed
STATinMED Research provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies. All STATinMED Research consultants hold academic positions with prestigious universities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2012 via BusinessWire

IMS Health Incorporated, acquired TTC LLC

synopsis: IMS Health has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical trials. TTC offers clients a robust set of clinical trial cost benchmarks, budgeting and negotiation tools.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: TTC LLC
TTC is the leader in global clinical trial cost benchmarking. With offices in Philadelphia, TTC has a proven track record in all aspects of outsourcing cost management, from the budgeting of protocols and clinical trials to negotiations with clinical sites and other providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/13/2020 via Company Press Release

IntegriChain, Inc., purchased Life Sciences Division from Cumberland Consulting Group, LLC

synopsis: IntegriChain, a leading Life Sciences data and managed services company that helps drive access to life-saving and life-changing medicines, announced that it has acquired Cumberland’s Life Science Division, a leading provider of managed services, advisory services and systems integration for contracts, pricing and revenue management.
buyer parent: Accel-KKR
buyer: IntegriChain, Inc.
IntegriChain delivers Life Sciences’ only comprehensive data and business process platform for market access. More than 220 manufacturers rely on IntegriChain’s analytics, applications to power their market access operations and harness the value of their channel, patient and payer data. "
seller parent: Tailwind Capital Partners
seller: Cumberland Consulting Group, LLC
Cumberland’s Life Science Division is a leading provider of managed services, advisory services and systems integration for contracts, pricing and revenue management. They offer a variety of scalable services for pharmaceutical manufacturers of all sizes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like TGaS Advisors, LLC


read more

TGaS Advisors, LLC

Elysia Group

Porterhouse Medical Group

Pharmerit International

KMR Group

The Nielsen Company, Inc.

Promedica, Inc

TGaS Advisors, LLC

Chesapeake Research Review

Double Helix

Source Healthcare Analytics, LLC

Medical Collective Intelligence Co. Ltd.

PharmARC Analytic Solutions Pvt. Ltd.

SDI Health LLC

Richard Day Research Inc.

Analytica International, Inc.

SDI Health LLC

TGaS Advisors, LLC

InforMed Direct

BioTrends Research Group, Inc.

read more

TGaS Advisors, LLC

TGaS Advisors, LLC

TGaS Advisors, LLC

read more

Bell Canyon Consulting

TGaS Advisors, LLC

read more

TGaS Advisors, LLC

The Frankel Group Associates LLC

CFS Clinical

DataRevive LLC

Tardis Medical Consultancy

Adjility Health

Kinetiq

Validant

Regulatory Professionals, Inc.

Registrar Corp

ProPharma Group

Mindlance

BioSoteria, Inc.

DT Associates

Putnam Associates

Tri Stat

STATinMed

Abacus International

TTC LLC

Cumberland Consulting Group, LLC

Geography
Matching Companies
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,298.52
EBITDA ($mm)
$178.30
EBIT ($mm)
$122.78
Net Income ($mm)
$57.45
Employees
7790
  • drill down
  • watch
Ticker: PGND
 
 
 
 
 
 
 
 
Press Ganey Associates, Inc.
Press Ganey Associates, Inc.
Press Ganey offers an integrated suite of solutions that enables enterprise transformation across the patient journey. Delivered through a cutting-edge digital platform, Press Ganey solutions address safety, clinical excellence, patient experience, and workforce engagement.
year
2016
rev ($mm)
$344.32
EBITDA ($mm)
$104.94
EBIT ($mm)
$60.70
Net Income ($mm)
$27.26
Employees
1058
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: PBSV
 
 
 
 
 
 
 
 
Pharma-Bio Serv Inc.
PharmaBio Serv offers a full range of Regulatory Compliance Quality Systems, Validation & Qualification Services and Technology Transfer based on the latest FDA guidelines, as well as day to day process support.
year
2008
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,298.52
EBITDA ($mm)
$178.30
EBIT ($mm)
$122.78
Net Income ($mm)
$57.45
Employees
7790
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: OTCPK:MDCL
 
 
 
 
 
 
 
 
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc. was established in March 2014. They have provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state.
year
2016
rev ($mm)
$0.82
EBITDA ($mm)
($0.18)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
4
  • drill down
  • watch